Features

While some would like to drape the mantle "The father of pharmacogenomics" on Richard Weinshilboum, M.D., the scientist parries: "The only thing that I'm father ...

X-rays have been a medical tool for more than a century. The exquisite details of CT scans have offered unique views of the inside of ...

Miroslav Dlacic's heart attack changed his life drastically — and seemingly forever. His damaged heart made him too tired to work in his garden or ...

For more than 60 years, Robert Kyle, M.D., has catalogued patient histories, archived blood samples and observed a vast number of people with plasma ...

Russ Stephens is an insulin-dependent diabetic. Like thousands of other people with type 1 diabetes, he injects himself with insulin before every meal and again ...

Mayo Clinic’s role in developing the first effective tuberculosis treatment Patricia Thomas was trying to keep up her spirits. Her cough was not improving. Already thin, ...

The term "teamwork" is widely used when talking about scientific research, but when it comes to the Mayo Clinic version, it means cross-disciplinary teams with ...

Since the 1980s, pneumocystis pneumonia, or PCP, has infected thousands of HIV/AIDS patients. For nearly three decades, Mayo Clinic internist Andrew Limper, M.D., has researched ...

Curiosity, unconventional thinking, and random chance drive research into new drugs for the treatment of kidney disease. Granulomatosis with polyangiitis—yes, it’s a mouthful. It’s ...

The last leg of the journey from discovery to patient care may be the most difficult: traversing the commercialization gap. Unless a treatment or technology can reach medical practice, years of research may be meaningless.